FDA to Decide on New COVID-19 Vaccine, Nebraska Health Officials Optimistic

Feb. 25, 2021, 3:53 p.m. ·


The Federal Drug Administration meets Friday to decide whether to give the new Johnson & Johnson COVID-19 vaccine, emergency use authorization.

Although the vaccine is less effective than the Moderna and Pfizer vaccine, with a reported 77% effective rate, Dr. Gary Anthone, the state’s chief medical officer, said there are multiple advantages with the new vaccine including the fact that it comes as a single dose and does not need to be kept in cold temperatures.

"Great News. We are so thrilled that now we are going to have three vaccines,” Anthone said.

The United States is expected to receive 20 million doses of the Johnson and Johnson vaccine. If it is authorized, Nebraska will be getting the vaccine sometime next week.